Holen Sie sich die Stockscreener-App
3.19
1.27%
0.04
Vorhandelsmarkt:
3.19
Schlusskurs vom Vortag:
$3.15
Offen:
$3.2
24-Stunden-Volumen:
753.63K
Relative Volume:
0.67
Marktkapitalisierung:
$181.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-82.44M
KGV:
-1.6968
EPS:
-1.88
Netto-Cashflow:
$-66.75M
1W Leistung:
+8.14%
1M Leistung:
+36.91%
6M Leistung:
+22.22%
1J Leistung:
-46.02%
1-Tages-Spanne:
$3.02
$3.24
1-Wochen-Bereich:
$2.93
$3.315
52-Wochen-Spanne:
$1.195
$6.75
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Firmenname
Black Diamond Therapeutics Inc
Sektor
Branche
Telefon
617-417-5868
Adresse
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Vergleichen Sie BDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
3.19 | 167.74M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform |
| 2024-07-31 | Eingeleitet | Raymond James | Outperform |
| 2023-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2023-06-30 | Hochstufung | Stifel | Hold → Buy |
| 2023-06-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-03-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-03-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Stifel | Hold |
| 2021-01-07 | Eingeleitet | Wedbush | Outperform |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-02-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-02-24 | Eingeleitet | Cowen | Outperform |
| 2020-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2020-02-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten
Is Black Diamond Therapeutics Inc. a good long term investmentUnstoppable profit momentum - Autocar Professional
Black Diamond Therapeutics Inc. Stock Analysis and ForecastTriple-digit profit margins - jammulinksnews.com
Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
What analysts say about Black Diamond Therapeutics Inc. stockPhenomenal investment performance - jammulinksnews.com
What drives Black Diamond Therapeutics Inc. stock priceMarket-leading capital gains - Autocar Professional
Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise - MSN
why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
Black Diamond Therapeutics discloses EGFR inhibitors for cancer - BioWorld MedTech
How Black Diamond Therapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser
What makes Black Diamond Therapeutics Inc. stock price move sharplyGroup Only Stock Signals - Newser
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of “Buy” from Analysts - Defense World
10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey
Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) dropped from Russell 2500 Index - MarketScreener
Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) dropped from Russell 2500 Value Index - MarketScreener
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Holdings Boosted by Bank of America Corp DE - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of “Buy” from Analysts - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street Zen - Defense World
Black Diamond’s 2025 Annual Stockholders Meeting Highlights - TipRanks
Black Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant Upside - Seeking Alpha
Wellington Management Group LLP Grows Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Squarepoint Ops LLC Buys 72,688 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded to Hold Rating by Wall Street Zen - Defense World
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Nuveen Asset Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Northern Trust Corp - Defense World
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewswire
17,317 Shares in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Bought by D. E. Shaw & Co. Inc. - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) & Fresh Tracks Therapeutics (NASDAQ:FRTX) Critical Comparison - Defense World
Brokerages Set Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Price Target at $14.60 - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at Wall Street Zen - Defense World
Black Diamond Therapeutics Reports Strong Q1 2025 Earnings - TipRanks
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):